Search Within

David A Verbel

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (6)
  2. Genitourinary Oncology Service (6)
  3. Molecular Pharmacology and Chemistry Program Faculty (6)
  4. Sloan Kettering Institute Faculty (6)
  5. Solid Tumor Oncology Division (6)
  6. Hematologic Malignancies, Division of (4)

More Groups

People
  1. Howard Scher (6)
  2. Susan Slovin (4)
  3. Govindaswami Ragupathi (3)
  4. Philip Livingston (3)
  5. Samuel Danishefsky (3)
  6. Celina Fernandez (2)

More People

Years
  1. 2005 (2)
  2. 2003 (1)
  3. 2002 (3)
Publications
  1. Clinical Cancer Research (2)
  2. Cancer Immunology, Immunotherapy (1)
  3. Journal of Clinical Oncology (1)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (1)
  5. Urology (1)
Publishers
  1. American Association for Cancer Research (3)
  2. American Society of Clinical Oncology (1)
  3. Elsevier Science, Inc. (1)
  4. Springer (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: Clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer
    Journal Article

    Slovin, S. F.; Ragupathi, G.; Musselli, C.; Fernandez, C.; Diani, M.; Verbel, D.; Danishefsky, S.; Livingston, P.; Scher, H. I.
    Cancer Immunology, Immunotherapy (2005)

    Fulltext@MSK | Save
  • Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy
    Journal Article

    Morris, M. J.; Akhurst, T.; Larson, S. M.; Ditullio, M.; Chu, E.; Siedlecki, K.; Verbel, D.; Heller, G.; Kelly, W. K.; Slovin, S.; more...
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: Clinical trial results with α-N-acetylgalactosamine-O- serine/threonine conjugate vaccine
    Journal Article

    Slovin, S. F.; Ragupathi, G.; Musselli, C.; Olkiewicz, K.; Verbel, D.; Kuduk, S. D.; Schwarz, J. B.; Sames, D.; Danishefsky, S.; Livingston, P. O.; more...
    Journal of Clinical Oncology (2003)

    Fulltext@MSK | Save
  • Thomsen-Friedenreich cluster (TF(c))-KLH conjugate vaccine plus the immunological adjuvant QS21 in prostate cancer (PC) patients in the minimal disease state
    Meeting Abstract

    Slovin, S. F.; Ragupathi, G.; Fernandez, C.; Randall, E.; Diani, M.; Verbel, D.; Bullock, A.; Recaldez, E.; Schwarz, J.; Kuduk, S.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save
  • 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts
    Journal Article

    Solit, D. B.; Zheng, F. F.; Drobnjak, M.; Münster, P. N.; Higgins, B.; Verbel, D.; Heller, G.; Tong, W.; Cordon-Cardo, C.; Agus, D. B.; more...
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer
    Journal Article

    Morris, M. J.; Akhurst, T.; Osman, I.; Nunez, R.; Macapinlac, H.; Siedlecki, K.; Verbel, D.; Schwartz, L.; Larson, S. M.; Scher, H. I.
    Urology (2002)

    Fulltext@MSK | Save